Improving quality of life and health outcomes of patients with psychosis through a new structured intervention for expanding social networks: SCENE (Work Package 5)

A randomised controlled trial of a structured intervention for expanding social networks in psychosis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN15815862

Enrollment

600

Registered

2019-03-26

Start date

2019-03-01

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychosis Mental and Behavioural Disorders

Interventions

Consent & baseline: Potentially eligible patients will be identified by members of their treating clinical team (depending on the local Trust policy this may include clinical studies’ officers), who

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: PATIENTS: 1. 18-65 years old 2. Diagnosis of psychosis-related condition (ICD-10 F20-29) 3. Capacity to provide informed consent 4. Ability to communicate in English 5. Limited social network size (three or less social contacts with non-first degree relatives in the previous week) 6. Low quality of life (Score 5 or less on MANSA quality of life assessment) CLINICIANS: 1. Mental health professional with experience of providing mental health care (e.g. psychiatrists, clinical psychologists, nurses, occupational therapists), minimum NHS Band 4 or equivalent experience 2. Aged 18 and over 3. Capacity to provide informed consent 4. Ability to communicate in English

Exclusion criteria

Exclusion criteria: PATIENTS: 1. Primary problem of current drug addiction 2. No capacity to provide written informed consent 3. An inpatient on a psychiatric ward at the time of recruitment

Design outcomes

Primary

Measure	Time frame
The primary outcome will be the subjective quality of life, measured on the Manchester Short Assessment of Quality of Life (MANSA) at the end of the intervention (6 months after recruitment). Timepoint(s): 6 months (primary outcome), 12 months and 18 months follow-up	—

Secondary

Measure	Time frame
Assessed at 6 months, 12 months and 18 months 1. Psychopathological symptoms Positive And Negative Syndrome Scale 2. Social situation (SIX) 3. Feeling of loneliness (UCLA Loneliness Scale) 4. Time spent in social activities (Time Use Survey) 5. Health-related quality of life (EQ-5D-5L) 6. Service use (Client Service Receipt Inventory)	—

Countries

England, United Kingdom

Contacts

Public ContactAgnes Chevalier

agnes.chevalier@nhs.net+44(0)2075404380 ext.2340

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 13, 2026